Key result
FHL-1 deficiency did not diminish right ventricular hypertrophy or hypertrophic signaling in mice subjected to pressure overload, indicating FHL-1 is not involved in maladaptive right ventricular remodeling.
Why the study?
FHL-1 deficiency blunts hypertrophic response in pressure-overloaded left ventricles, but its role in right heart hypertrophy had not yet been addressed.
Does FHL-1 deficiency prevent maladaptive right ventricular remodeling and dysfunction in a mouse model of pressure overload?
Does FHL-1 deficiency prevent maladaptive right ventricular remodeling and dysfunction in a mouse model of pressure overload?
Unlike in the left ventricle, FHL-1 deficiency does not protect against pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
FHL-1 is not a target for right ventricular pressure overload; leaves open chamber-specific mechanisms versus left ventricle.
Aims The cytoskeletal signaling protein four and-a-half LIM domains 1 (FHL-1) has recently been identified as a novel key player in pulmonary hypertension as well as in left heart diseases. In this regard, FHL-1 has been implicated in dysregulated hypertrophic signaling in pulmonary arterial smooth muscle cells leading to pulmonary hypertension. In mice, FHL-1-deficiency (FHL-1 −/− ) led to an attenuated hypertrophic signaling associated with a blunted hypertrophic response of the pressure-overloaded left ventricle (LV). However, the role of FHL-1 in right heart hypertrophy has not yet been addressed. Methods and results We investigated FHL-1 expression in C57Bl/6 mice subjected to chronic biomechanical stress and found it to be enhanced in the right ventricle (RV). Next, we subjected FHL-1 −/− and corresponding wild-type mice to pressure overload of the RV by pulmonary arterial banding for various time points. However, in contrast to the previously published study in LV-pressure overload, which was confirmed here, RV hypertrophy and hypertrophic signaling was not diminished in FHL-1 −/− mice. In detail, right ventricular pressure overload led to hypertrophy, dilatation and fibrosis of the RV from both FHL-1 −/− and wild-type mice. RV remodeling was associated with impaired RV function as evidenced by reduced tricuspid annular plane systolic excursion. Additionally, PAB induced upregulation of natriuretic peptides and slight downregulation of phospholamban and ryanodine receptor 2 in the RV. However, there was no difference between genotypes in the degree of expression change. Conclusion FHL-1 pathway is not involved in the control of adverse remodeling in the pressure overloaded RV.
No takes yet. Share an insight, caveat, or question.
Veith et al. (2020) studied Right ventricular hypertrophy. FHL-1 knockout (FHL-1-/-) vs. Wild-type (WT) littermates was evaluated on Right ventricular remodeling and dysfunction. FHL-1 deficiency did not diminish right ventricular hypertrophy or hypertrophic signaling in mice subjected to pressure overload, indicating FHL-1 is not involved in maladaptive right ventricular remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: